- Case study
- Open Access
Langerhans cell histiocytosis in the adult lumbar spine: case report
© The Author(s) 2016
- Received: 22 June 2016
- Accepted: 5 August 2016
- Published: 23 August 2016
Langerhans cell histiocytosis (LCH) occurs rarely in the spine of adults. The radiological findings usually resemble vertebral tumors. Etiology of LCH has not been clearly established yet. Therapeutic approaches are still controversial. We describe a case of LCH in an adult spine.
A patient who presented with low back pain had an osteolytic lesion in the L1 vertebral body without neurological deficits, and fluoroscopy-guided needle biopsy of the L1 vertebral body was performed. The immunohistochemical diagnosis confirmed LCH. The patient was successfully treated with conservative methods.
The choice of appropriate therapy is very important, with treatment options varying from watch-and to aggressive treatment.
LCH is considered as a pediatric disease that is extremely rare in the spine of adults and should be include in the differential diagnosis of osteolytic vertebral lesions. Conservative treatment is best choice for a patient with LCH without neurological deficit or spinal instability.
- Langerhans cell histiocytosis
- Adult spine
- Osteolytic lesion
- Conservative method
Langerhans cell histiocytosis (LCH) is a clonal proliferative disease characterized by infiltration of single or multiple organs by specific dendritic cells that resemble the normal epidermal Langerhans cell. LCH is considered a pediatric disease and is extremely rare in the spine of adults. Spinal involvement occurs in 6.5–25 % of all skeletal lesions. In the spine, LCH mainly involves the vertebral bodies, with a predilection for the thoracic spine (54 %) followed by the lumbar (35 %) and cervical spine (11 %) (Abu-Bonsrah et al. 2016). Only a small number of cases of LCH in the adult lumbar spine have been reported in the English literature (Huang et al. 2010; Demirci 2004; Bavbek et al. 2004; Bilge et al. 1995). This article describes the case of 35-year-old man diagnosed with LCH presenting as an osteolytic lesion of the L1 vertebral body.
Langerhans cell histiocytosis (LCH) is a rare, clonal proliferative disease characterized by infiltration of single or multiple organs by specific dendritic cells that resemble the normal epidermal Langerhans cell. LCH comprises a spectrum of disorders. Localized disease is described as eosinophilic granuloma, while multisystem forms of LCH have eponymous descriptions such as Hand-Schüller-Christian disease, Letterer-Siwe disease, and systemic histiocytosis X. The present case was a solitary osseous lesion without systemic involvement. Although LCH most commonly occurs in the first two decades of life, it may affect patients of any age, from infants to elderly individuals. Among children, it has an annual incidence of 3-5 cases per million. In adults, the disease is rare, with an estimated prevalence of 1–2 cases per million/year (Azouz et al. 2005). Bone is the most common organ affected by LCH. The most frequent sites of the osseous lesions of LCH are the skull, femur, mandible, pelvis, and spine. LCH in the spine is reported to mainly involve the vertebral bodies, occurring in 6.5–25 % of cases, with the most frequent site being the thoracic vertebrae (54 %) in children, and the cervical vertebrae in adults. In the present case, LCH occurred in the lumbar vertebral body in an adult spine. Well-defined osteolytic lesions can be seen on radiological studies, although osteoblastic lesions can rarely develop (Beltran et al. 1993; Kilborn et al. 2003). In children, most of the vertebral body volume is infiltrated by LCH, causing complete collapse, with a characteristic “vertebra plana” appearance. In adults, a relatively small volume of the vertebral body is affected, and LCH of the body is present without collapse. CT can show some characteristic signs such as osteolytic lesions with a sclerotic margin. MRI can show a hypointense or heterogeneous signal intensity lesion on T1-weighted images and a hyperintense lesion on T2-weighted images. In the case of our patient, plain X-ray, CT, and MRI were performed, and an osteolytic lesion of the L1 vertebral body was identified. Although characteristic clinical and radiological features suggest the diagnosis, these features cannot provide a definitive diagnosis. Histological confirmation is always required in adults (Huang et al. 2010). Malignant tumor, osteomyelitis, aneurysmal bone cyst, Ewing’s sarcoma, osteoblastoma, Gaucher’s disease, and acute leukemia must be differentiated (Reddy et al. 2000). The diagnosis of LCH is confirmed by immunohistochemical staining for CD-1a and S-100 protein (Azouz et al. 2005). Spinal LCH is self-limiting and the prognosis is usually good. A variety of treatment modalities for spinal LCH have been reported, including conservative management, intralesional steroid injection, radiation therapy, chemotherapy, and curettage with or without reconstructive surgery (Puigdevall et al. 2008; Garg et al. 2003; Bertram et al. 2002). Mild, isolated involvement of the spine without neurological deficits or spinal instability can be managed with conservative methods such as simple observation, nonsteroidal anti-inflammatory drugs, immobilization, or casting with or without initial bed rest. Although radiation therapy has the potential for secondary malignancy and vertebral growth-plate damage in the skeletally immature patient, low-dose radiation therapy appears safe and effective for adult patients with progressive spinal lesions or neurological impairment. Chemotherapy, especially modest dose of ARA-C (100 mg/m2 daily for 5 days, repeated monthly for 6) is suggested for disseminated LCH with multiple bone lesions or multisystem disease (Cantu et al. 2012). Recent studies have been reported that administration of pegylated interferon-alpha can be helpful for treatment of LCH by inducing anti-tumoral response (Furudate et al. 2014). A large fraction of LCH cases appear to be associated with BRAF mutations and those could potentially benefit from treatment with a BRAF inhibitor (Badalian-Very et al. 2010). Surgery should be reserved for selected cases with severe mechanical instability, deformity, or neurological deficit due to compressionBecause spinal LCH is self-limiting, most authors have recommended conservative treatment for disease without neurological or mechanical complications, as in our case.
LCH is considered a pediatric disease that is extremely rare in the spine of adults. However, it should be included in the differential diagnosis of osteolytic vertebral lesions in adults. Conservative treatment is a good choice for a patient with LCH without neurological deficits or spinal instability.
BWH: Operated the patient. BJM: Wrote the first summary of the work in the original language and reviewed all the others. YJK, SDK and KYC: Revised the manuscript. JKL: Reviewed the chart and published literature. All authors read and approved the final manuscript.
The present work was approved by the Ethical review committee of Chonnam National University Hospital and Medical School. This study was supported by a grant (CRI 13902-21) from the Chonnam National University Hospital Biomedical Research Institute.
The authors declare that they have no competing interests.
The patient and guardian have consented to the submission of the case report. (IRB of Chonnam National University Hospital).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Abu-Bonsrah N, Goodwin CR, Crane GM, Abiola G, Sciubba DM (2016) Langerhans cell histiocytosis of the cervical spine. Spine J 16(1):e11–e12. doi:10.1016/j.spinee.2015.08.010 View ArticleGoogle Scholar
- Azouz EM, Saigal G, Rodriguez MM, Podda A (2005) Langerhans’ cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol 35(2):103–115. doi:10.1007/s00247-004-1262-0 View ArticleGoogle Scholar
- Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116(11):1919–1923. doi:10.1182/blood-2010-04-279083 View ArticleGoogle Scholar
- Bavbek M, Atalay B, Altinors N, Caner H (2004) Spontaneous resolution of lumbar vertebral eosinophilic granuloma. Acta Neurochir (Wien) 146(2):165–167. doi:10.1007/s00701-003-0182-3 View ArticleGoogle Scholar
- Beltran J, Aparisi F, Bonmati LM, Rosenberg ZS, Present D, Steiner GC (1993) Eosinophilic granuloma: MRI manifestations. Skelet Radiol 22(3):157–161View ArticleGoogle Scholar
- Bertram C, Madert J, Eggers C (2002) Eosinophilic granuloma of the cervical spine. Spine 27(13):1408–1413View ArticleGoogle Scholar
- Bilge T, Barut S, Yaymaci Y, Alatli C (1995) Solitary eosinophilic granuloma of the lumbar spine in an adult. Case report. Paraplegia 33(8):485–487. doi:10.1038/sc.1995.99 View ArticleGoogle Scholar
- Cantu MA, Lupo PJ, Bilgi M, Hicks MJ, Allen CE, McClain KL (2012) Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. PLoS ONE 7(8):e43257. doi:10.1371/journal.pone.0043257 View ArticleGoogle Scholar
- Demirci I (2004) Adult eosinophilic granuloma of the lumbar spine with atypical dissemination. Case report: a long-term follow-up. Zentralbl Neurochir 65(2):84–87. doi:10.1055/s-2004-816240 View ArticleGoogle Scholar
- Furudate S, Fujimura T, Kambayashi Y, Kawano M, Ogasawara K, Tsukada A, Tamabuchi E, Haga T, Hashimoto A, Aiba S (2014) Successful treatment of adult onset Langerhans cell histiocytosis with bi-weekly administration of pegylated interferon-alpha. Acta Derm Venereol 94(5):611–612. doi:10.2340/00015555-1807 View ArticleGoogle Scholar
- Garg S, Mehta S, Dormans JP (2003) An atypical presentation of Langerhans cell histiocytosis of the cervical spine in a child. Spine 28(21):E445–E448. doi:10.1097/01.brs.0000096462.51682.0f View ArticleGoogle Scholar
- Huang W, Yang X, Cao D, Xiao J, Yang M, Feng D, Huang Q, Wu Z, Zheng W, Jia L, Wu S (2010) Eosinophilic granuloma of spine in adults: a report of 30 cases and outcome. Acta Neurochir (Wien) 152(7):1129–1137. doi:10.1007/s00701-010-0644-3 View ArticleGoogle Scholar
- Kilborn TN, Teh J, Goodman TR (2003) Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings. Clin Radiol 58(4):269–278View ArticleGoogle Scholar
- Puigdevall M, Bosio S, Hokama J, Maenza R (2008) Langerhans cell histiocytosis of the atlas in the pediatric spine: total reconstitution of the bone lesion after nonoperative treatment. A report of two cases. J Bone Joint Surg 90(9):1994–1997. doi:10.2106/jbjs.g.01352 View ArticleGoogle Scholar
- Reddy PK, Vannemreddy PS, Nanda A (2000) Eosinophilic granuloma of spine in adults: a case report and review of literature. Spinal Cord 38(12):766–768View ArticleGoogle Scholar